Warning on unknown breast cancer drugs
The Egyptian Drug Authority has warned against the circulation of unidentified packaging of the medications Bosipalib and Tokatinib, which are used for cancer treatment. The Authority emphasized the need to withdraw these two drugs from the markets due to uncertainty regarding their source and safety, in order to ensure patient safety.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)